Reproducibility of dynamic contrast-enhanced MR imaging: why we should care.
暂无分享,去创建一个
[1] D. Collins,et al. Advanced solid tumors treated with cediranib: comparison of dynamic contrast-enhanced MR imaging and CT as markers of vascular activity. , 2012, Radiology.
[2] Steve Halligan,et al. Quantitative assessment of colorectal cancer tumor vascular parameters by using perfusion CT: influence of tumor region of interest. , 2008, Radiology.
[3] H. Huisman,et al. Imaging vascular function for early stage clinical trials using dynamic contrast-enhanced magnetic resonance imaging , 2012, European Radiology.
[4] Steven R. Breault,et al. Reproducibility of dynamic contrast-enhanced MR imaging. Part II. Comparison of intra- and interobserver variability with manual region of interest placement versus semiautomatic lesion segmentation and histogram analysis. , 2013, Radiology.
[5] A. Harris,et al. Phase I Trial of Combretastatin A4 Phosphate (CA4P) in Combination with Bevacizumab in Patients with Advanced Cancer , 2012, Clinical Cancer Research.
[6] Daniel Balvay,et al. Reproducibility of dynamic contrast-enhanced MR imaging. , 2013, Radiology.
[7] J R Griffiths,et al. Clinical studies. , 2005, Advances in pharmacology.
[8] Matthew S Davenport,et al. Reproducibility of dynamic contrast-enhanced MR imaging. Part I. Perfusion characteristics in the female pelvis by using multiple computer-aided diagnosis perfusion analysis solutions. , 2013, Radiology.
[9] Steve Halligan,et al. Quantitative tumor perfusion assessment with multidetector CT: are measurements from two commercial software packages interchangeable? , 2007, Radiology.
[10] M. P. Hayball,et al. Current status and guidelines for the assessment of tumour vascular support with dynamic contrast-enhanced computed tomography , 2012, European Radiology.